Observational studyHuman

[Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study)]

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023. Mashin VV, Belova LA, Kotova EY and 5 others.

Study type

Observational study

Subjects

Human participants (PubMed MeSH: Humans)

Journal

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published

2023

PubMed

PMID 38147380 ↗

DOI

10.17116/jnevro202312312134 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Cortexin →

Indexed under

MeSH terms assigned by the National Library of Medicine.

AgedFemaleHumansMaleMiddle AgedAntibodiesAtherosclerosisBrainBrain IschemiaCognitive DysfunctionIntercellular Signaling Peptides and Proteins

Other papers on Cortexin

Journal article · 2025

Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay

Journal article · 2023

Cortexin® Ameliorates High Glucose-Induced Neuropathy in Cultured Rat Sensory Neurons

Journal article · 2021

[Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency]

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page